Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12ASTELLAS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-4102

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

02

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-4104

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

03

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-4102

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

04

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-4103

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

05

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-4101

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

06

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-4102

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

07

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-4101

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

08

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-4104

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

09

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 213674

Patent Use Code : U-4103

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank

10

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ENZALUTAMIDE

US Patent Number : 12161628

Drug Substance Claim :

Drug Product Claim :

Application Number : 203415

Patent Use Code : U-4103

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-23

blank